Advertisement

Topics

Advertisement

Solid Tumors

Hematologic Malignancies

Issues in Oncology

Supportive Care

Advertisement

Advertisement



Jan
22
Today In Oncology
Does Proton Pump Inhibitor Use Affect Cognition in Breast Cancer Survivors?
Using T-Cell Fraction to Predict Melanoma Recurrence
irAEs and Recurrence-Free Survival With Adjuvant Immunotherapy vs Placebo in Stage III Melanoma
Extended Letrozole Boosts Disease-Free Survival in 10-Year Update of NSABP B-42 Trial
Brentuximab Vedotin Plus Nivolumab in Hodgkin Lymphoma
View More 
Advertisement
Most Read Stories
FDA Pipeline: Priority Reviews in Ovarian Cancer, Prostate Cancer, and NSCLC
Maintenance Bevacizumab With or Without Pemetrexed in Advanced Nonsquamous NSCLC
When Can Patients With Gleason 6 Prostate Cancer Safely Undergo Active Surveillance?
How I Work up the Patient with Thrombocytosis
Use of Artificial Intelligence for Diagnosing and Grading Prostate Cancer
View More 
Most Viewed Videos
Rashmi K. Murthy, MD, on HER2-Positive Metastatic Breast Cancer: HER2CLIMB Trial of Tucatinib, Capecitabine, and Trastuzumab
Solange Peters, MD, PhD, on NSCLC: CheckMate 227 Trial of Nivolumab/Ipilimumab vs Chemotherapy
Nicoletta Colombo, MD, on Lenvatinib/Pembrolizumab for Advanced Endometrial Cancer
Francesca Battaglin, MD, on Colorectal Cancer: Using Genetic Variants to Predict Treatment Efficacy
Nadine M. Tung, MD, on HER2-Negative Breast Cancer: INFORM Trial of Cisplatin vs Doxorubicin/Cyclophosphamide
View More 
© 2020 HSP News Service, L.L.C.